RNA5SP465: A Potential Drug Target and Biomarker (G100873709)
RNA5SP465: A Potential Drug Target and Biomarker
RNA5SP465 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the T-cell receptor (TCR), which is a critical molecule that plays a crucial role in the immune system. TCR is composed of a variable region and a constant region, and it is expressed in the T-cells, B-cells, and natural killer cells. RNA5SP465 is a highly conserved non-coding RNA molecule that is highly expressed in all tissues of the body, including the brain, heart, liver, and muscle.
RNA5SP465 as a Drug Target
RNA5SP465 has been identified as a potential drug target due to its critical role in the regulation of TCR, which is a key regulator of immune responses. TCR is a transmembrane protein that consists of a variable region and a constant region. The variable region of TCR contains the T-cell receptor alpha chain, which is responsible for recognizing antigens. The constant region of TCR contains the T-cell receptor beta chain, which is responsible for transmitting the signal from the T-cell receptor alpha chain to the cell's nucleus.
RNA5SP465 is a key regulator of TCR, and it is involved in the regulation of the T-cell receptor alpha chain. It is a highly conserved non-coding RNA molecule that is highly expressed in all tissues of the body, including the brain, heart, liver, and muscle. RNA5SP465 is a good candidate for a drug target due to its critical role in the regulation of TCR, which is a key regulator of immune responses.
RNA5SP465 as a Biomarker
RNA5SP465 has also been identified as a potential biomarker for a variety of diseases, including cancer, autoimmune diseases, and neurodegenerative diseases. RNA5SP465 is a highly conserved non-coding RNA molecule that is highly expressed in all tissues of the body, including the brain, heart, liver, and muscle. This suggests that it may be a useful biomarker for a variety of diseases.
RNA5SP465 is a good candidate for a biomarker due to its critical role in the regulation of TCR, which is a key regulator of immune responses. TCR is a transmembrane protein that consists of a variable region and a constant region. The variable region of TCR contains the T-cell receptor alpha chain, which is responsible for recognizing antigens. The constant region of TCR contains the T-cell receptor beta chain, which is responsible for transmitting the signal from the T-cell receptor alpha chain to the cell's nucleus. RNA5SP465 is a highly conserved non-coding RNA molecule that is highly expressed in all tissues of the body, including the brain, heart, liver, and muscle. This suggests that it may be a useful biomarker for a variety of diseases.
Conclusion
In conclusion, RNA5SP465 is a highly conserved non-coding RNA molecule that is highly expressed in all tissues of the body. It is a key regulator of the T-cell receptor and has been identified as a potential drug target and biomarker. RNA5SP465 may be a useful target for the development of new treatments for a variety of diseases, including cancer, autoimmune diseases, and neurodegenerative diseases. Further research is needed to fully understand the role of RNA5SP465 as a drug target and biomarker.
Protein Name: RNA, 5S Ribosomal Pseudogene 465
The "RNA5SP465 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNA5SP465 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
RNA5SP479 | RNA5SP493 | RNA5SP496 | RNA5SP497 | RNA5SP505 | RNA5SP511 | RNA5SP518 | RNA5SP52 | RNA5SP53 | RNA5SP54 | RNA5SP57 | RNA5SP63 | RNA5SP85 | RNA5SP91 | RNASE1 | RNASE10 | RNASE11 | RNASE11-AS1 | RNASE12 | RNASE13 | RNASE2 | RNASE2CP | RNASE3 | RNASE4 | RNASE6 | RNASE7 | RNASE8 | RNASE9 | RNASEH1 | RNASEH1-DT | RNASEH2A | RNASEH2B | RNASEH2B-AS1 | RNASEH2C | RNASEH2CP1 | RNASEK | RNASEL | RNASET2 | RND1 | RND2 | RND3 | RNF10 | RNF103 | RNF103-CHMP3 | RNF11 | RNF111 | RNF112 | RNF113A | RNF113B | RNF114 | RNF115 | RNF121 | RNF122 | RNF123 | RNF125 | RNF126 | RNF126P1 | RNF128 | RNF13 | RNF130 | RNF133 | RNF135 | RNF138 | RNF138P1 | RNF139 | RNF139-DT | RNF14 | RNF141 | RNF144A | RNF144B | RNF145 | RNF146 | RNF148 | RNF149 | RNF150 | RNF151 | RNF152 | RNF157 | RNF157-AS1 | RNF165 | RNF166 | RNF167 | RNF168 | RNF169 | RNF17 | RNF170 | RNF175 | RNF180 | RNF181 | RNF182 | RNF183 | RNF185 | RNF186 | RNF187 | RNF19A | RNF19B | RNF2 | RNF20 | RNF207 | RNF208
